Stocksigma LogoStocksigma Logo

Remus Pharmaceuticals Seeks Shareholder Approval for Main Board Migration

Remus Pharmaceuticals Limited issued a Postal Ballot Notice seeking shareholder approval via special resolution to migrate its equity shares (face value

Remus Pharmaceuticals Seeks Shareholder Approval for Main Board Migration

Remus Pharmaceuticals Ltd · Annual General Meeting · 05 Sept 2026, 7:40 pm

Remus Pharmaceuticals Seeks Shareholder Approval for Main Board Migration Remus Pharmaceuticals Limited issued a Postal Ballot Notice seeking shareholder approval via special resolution to migrate its equity shares (face value ₹10.00) from the NSE Emerge platform to the Main Boards of NSE and BSE. The cut-off date for voting eligibility is 28th Aug'26. Remote e-voting runs from 7th Sep'26 to 6th Oct'26, with results announced on or before 8th Oct'26. The migration aims to enhance liquidity, visibility, and broader investor participation, subject to statutory approvals and non-promoter voting thresholds per SEBI ICDR regulations.

Original exchange filing (PDF)

More announcements from Remus Pharmaceuticals Ltd

All Remus Pharmaceuticals Ltd announcements